Cigna expands insurance coverage for weight-loss drugs with a 15% annual spending cap.
Cigna Group has announced an initiative to expand insurance coverage for weight-loss drugs, limiting how much health plans and employers spend on popular treatments like Novo Nordisk's Wegovy and Eli Lilly's Zepbound each year. The company's pharmacy benefits manager will cap spending increases at 15% annually, a move aimed at easing concerns about GLP-1 treatments' high costs while potentially increasing access to the drugs.
March 07, 2024
10 Articles